NASDAQ:RVPH

Reviva Pharmaceuticals Holdings Stock Forecast

etoro logo Buy RVPH
*Your capital is at risk
$0.695
+0.0350 (+5.30%)
At Close: Jun 23, 2026
AI Analysis AI Analysis of RVPH AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add RVPH to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Big movements in Reviva Pharmaceuticals Holdings, Inc. stock price on Tuesday moving 14.43% between high and low
(Updated on Jun 23, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Jun 23, 2026

The Reviva Pharmaceuticals Holdings, Inc. stock price gained 5.30% on the last trading day (Tuesday, 23rd Jun 2026), rising from $0.660 to $0.695. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 14.43% from a day low at $0.610 to a day high of $0.698. The price has risen in 6 of the last 10 days and is up by 3.89% over the past 2 weeks. Volume fell on the last day by -8 thousand shares and in total, 10 thousand shares were bought and sold for approximately $6.66 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.725 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -29.77% during the next 3 months and, with a 90% probability hold a price between $0.153 and $0.509 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

RVPH Signals & Forecast

The Reviva Pharmaceuticals Holdings, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $0.651 and $0.601. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, June 11, 2026, and so far it has fallen -8.55%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Reviva Pharmaceuticals Holdings, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.660 and $0.600. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Reviva Pharmaceuticals Holdings, Inc. finds support just below today's level at $0.660. If this is broken, then the next support from accumulated volume will be at $0.600 and $0.585.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0880 between high and low, or 14.43%. For the last week the stock has had daily average volatility of 11.40%.

Our recommended stop-loss: $0.658 (-5.32%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 7 days ago.)

Trading Expectations (RVPH) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Reviva Pharmaceuticals Holdings, Inc. to open at $0.668, and during the day (based on 14 day Average True Range), to move between $0.649 and $0.741, which gives a possible trading interval of +/-$0.0911 (+/-14.03%) up or down from last closing price. If Reviva Pharmaceuticals Holdings, Inc. takes out the full calculated possible swing range there will be an estimated 14.03% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.720 (3.60%) than the support at $0.660 (5.04%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Reviva Pharmaceuticals Holdings, Inc. stock A Buy?

Reviva Pharmaceuticals Holdings, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.217 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $0.668 ( 3.93%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

RVPH Performance

Trading levels for RVPH

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.756 8.73%
R2 0.722 3.89%
R1 0.701 0.90%
Price 0.695
S1 0.634 -8.77%
S2 0.613 -11.76%
S3 0.580 -16.59%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.85 22.30%
R2 0.783 12.66%
R1 0.720 3.60%
Price 0.695
S1 0.660 -5.04%
S2 0.600 -13.67%
S3 0.585 -15.83%

FAQ

What is the symbol for Reviva Pharmaceuticals Holdings, Inc. Stock and on which exchange is it traded?
The symbol for Reviva Pharmaceuticals Holdings, Inc. is RVPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Reviva Pharmaceuticals Holdings, Inc. Stock?
Reviva Pharmaceuticals Holdings, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Reviva Pharmaceuticals Holdings, Inc. Stock?
Reviva Pharmaceuticals Holdings, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Reviva Pharmaceuticals Holdings, Inc. Stock.

What's the current price of Reviva Pharmaceuticals Holdings, Inc. Stock?
As of the end of day on the Jun 23, 2026, the price of an Reviva Pharmaceuticals Holdings, Inc. (RVPH) share was $0.695.

What is the 52-week high and low for Reviva Pharmaceuticals Holdings, Inc. Stock?
The 52-week high for Reviva Pharmaceuticals Holdings, Inc. Stock is $17.20 and the 52-week low is $0.262.

What is the market capitalization of Reviva Pharmaceuticals Holdings, Inc. Stock?
As of the Jun 23, 2026, the market capitalization of Reviva Pharmaceuticals Holdings, Inc. is 2.369M.

When is the next earnings date for Reviva Pharmaceuticals Holdings, Inc.?
The upcoming earnings date for Reviva Pharmaceuticals Holdings, Inc. is Aug 13, 2026.
Click to get the best stock tips daily for free!
ABOUT REVIVA PHARMACEUTICALS HOLDINGS, INC.
Reviva Pharmaceuticals Holdings
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE